Latest News

Adolescent and young adult (AYA) survival trends


 

The good news : AYA survival improvement was at least as large as in younger children and older adults comparing deaths in two time periods, 1988-2000 and 2001-2014, in a California Cancer Registry.

The bad news: There was no statistically significant difference in survival between time periods for patients with bone and soft tissue sarcoma.

Recommended Reading

CAR T cells home in on HER2 in advanced sarcomas
MDedge Hematology and Oncology
From the journals: sarcoma around the world
MDedge Hematology and Oncology
Sarcoma—rare, but not insignificant
MDedge Hematology and Oncology
EHR default order slashes unnecessary imaging during palliative RT
MDedge Hematology and Oncology
FDA approves Turalio for symptomatic tenosynovial giant cell tumor
MDedge Hematology and Oncology
Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defects
MDedge Hematology and Oncology
Clinical trials in sarcoma bring hope and promise
MDedge Hematology and Oncology
Significant clinical response induced by vismodegib in advanced sarcoma: Hedgehog pathway inhibition
MDedge Hematology and Oncology
SFA awards grants to 15 researchers
MDedge Hematology and Oncology
Conference Coverage: ASCO 2019
MDedge Hematology and Oncology